Hester Biosciences Limited (BOM:524669)
India · Delayed Price · Currency is INR | Market Cap | 11.75B |
| Revenue (ttm) | 3.11B |
| Net Income (ttm) | 438.44M |
| Shares Out | 8.51M |
| EPS (ttm) | 50.01 |
| PE Ratio | 27.62 |
| Forward PE | n/a |
| Dividend | 7.00 (0.49%) |
| Ex-Dividend Date | Aug 6, 2025 |
| Volume | 463 |
| Average Volume | 193 |
| Open | 1,460.30 |
| Previous Close | 1,459.75 |
| Day's Range | 1,404.70 - 1,460.30 |
| 52-Week Range | 1,246.75 - 2,347.70 |
| Beta | 0.07 |
| RSI | 25.82 |
| Earnings Date | Jan 30, 2026 |
About Hester Biosciences
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek’s disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella abortus, lumpy skin disease, contagio... [Read more]
Financial Performance
In 2024, Hester Biosciences's revenue was 3.12 billion, an increase of 0.41% compared to the previous year's 3.11 billion. Earnings were 274.88 million, an increase of 45.52%.
Financial StatementsNews
Q1 2026 Hester Biosciences Ltd Earnings Call Transcript
Q1 2026 Hester Biosciences Ltd Earnings Call Transcript
Hester Biosciences shares rally 15% as Q1 profit soars 131% YoY to Rs 17.3 crore, revenue rises 2%
Hester Biosciences shares surged over 15% on Friday following the release of its robust Q1 FY26 earnings. The company posted a sharp improvement in profitability, with net profit more than doubling ye...
India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc.
Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 06, 2025 (GLOBE NEWSWIRE) -- The India animal healthcare market is experiencing significant growth, driven by a rising livestock popula...
Hester Biosciences shares surge over 11% following strong Q2 FY25 performance
Hester Biosciences’ shares soared by 11.21% today, reaching ₹2,474.65, following the announcement of robust Q2 FY25 results. The company’s strong financial performance has sparked investor confidence,...
Hester Biosciences Q2: Revenue jumps 18.8% YoY to ₹83.69 crores, PAT surges 107.4% YoY to ₹8.39 crores
Hester Biosciences, a leading player in the animal healthcare sector, has reported an impressive financial performance for Q2 FY25. The company’s consolidated results indicate strong growth in revenue...